Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Molecular Cell|April 30, 2024
GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignanciesSalima Benbarche, Jose Mario Bello Pineda, Laura Baquero Galvis, et al.Nature Cancer|October 23, 2023
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemiaKatherine Knorr, Jahan Rahman, Caroline Erickson, et al.Cell Reports|May 13, 2014
The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compoundJake Shortt, Andy K Hsu, Benjamin P Martin, et al.Science Advances|September 12, 2020
CDK13 cooperates with CDK12 to control global RNA polymerase II processivityZheng Fan, Jennifer R Devlin, Simon J Hogg, et al.Leukemia|April 23, 2022
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphomaJonathan Wong, Emily Gruber, Belinda Maher, et al.Science Advances|September 14, 2022
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restrictionKenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson, et al.Cancer Discovery|July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic TransformationSisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.Nature Genetics|April 13, 2021
Minor intron retention drives clonal hematopoietic disorders and diverse cancer predispositionDaichi Inoue, Jacob T Polaski, Justin Taylor, et al.Cancer Cell|December 23, 2022
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemiaEric Wang, Jose Mario Bello Pineda, Won Jun Kim, et al.Cell Reports|August 22, 2023
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunityImran G House, Emily B Derrick, Kevin Sek, et al.Pageof 4